Canini, Davide
Martini, Flavio
Cazzaniga, Stefano
Miotti, Tea
Pacenza, Beatrice
D’Adamo, Sarah
Ballottari, Matteo
Funding for this research was provided by:
HORIZON EUROPE European Innovation Council (101099476)
Article History
Received: 16 March 2024
Accepted: 24 November 2024
First Online: 29 November 2024
Declarations
:
: Not applicable.
: Not applicable.
: Authors declare a competing financial interest: a patent application about the use of the BKT gene has been submitted by the University of Verona and granted at national level (Patent application n. 102021000027824 and PCT/IB2022/060381 “modified β-carotene ketolase (BKT), corresponding nucleic acid and microalgae strain comprising the same) having M.B. and S.C. among inventors. M.B. is the CEO and shareholder of asteasier srl, a company which could commercially exploit the results reported in this paper.